{"id":448931,"date":"2026-11-08T13:35:08","date_gmt":"2026-11-08T13:35:08","guid":{"rendered":"https:\/\/www.europesays.com\/se\/448931\/"},"modified":"2026-11-08T13:35:08","modified_gmt":"2026-11-08T13:35:08","slug":"forlorade-ogat-under-studie-och-nekas-av-lakemedelsforsakringen","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/se\/448931\/","title":{"rendered":"F\u00f6rlorade \u00f6gat under studie \u2013 och nekas av l\u00e4kemedelsf\u00f6rs\u00e4kringen"},"content":{"rendered":"<p><strong>Jesper Bj\u00f6rkman<\/strong>, tidigare back i Helsingborgs IF, har ALS. Han deltog i en l\u00e4kemedelsstudie i Sk\u00e5ne som skulle unders\u00f6ka om ett nytt l\u00e4kemedel kunde bromsa sjukdomen. Medicinen s\u00e4nkte hans immunf\u00f6rsvar kraftigt, och ett virus aktiverades.\u00a0<\/p>\n<p>Han blev blind p\u00e5 ena \u00f6gat, fick en pl\u00e5gsam hudreaktion och en livshotande lunginflammation, och \u00f6gat fick tas bort.\u00a0<\/p>\n<p>Det ber\u00e4ttade hans l\u00e4kare, neurologen <strong>Christer Nilsson<\/strong>, f\u00f6r <a href=\"https:\/\/lakartidningen.se\/nyheter\/als-patient-nekas-ersattning-trots-svara-biverkningar-lakare-rasar\/\" rel=\"nofollow noopener\" target=\"_blank\">L\u00e4kartidningen<\/a>. Enligt Helsingborgs Dagblad har Jesper Bj\u00f6rkman \u00e4nd\u00e5 inte f\u00e5tt n\u00e5gon ers\u00e4ttning, skriver <a href=\"https:\/\/www.pressen.se\/1371664182.html\" rel=\"nofollow noopener\" target=\"_blank\">Pressen<\/a>.<\/p>\n<p><strong>MISSA INTE: <\/strong><a href=\"https:\/\/www.news55.se\/privatekonomi\/skanker-du-till-valgorenhet-sa-undviker-du-en-skattesmall\/\" rel=\"nofollow noopener\" target=\"_blank\">Din g\u00e5va kan kosta dig en rej\u00e4l skattesm\u00e4ll<\/a><\/p>\n<p>S\u00e5 fungerar l\u00e4kemedelsf\u00f6rs\u00e4kringen<\/p>\n<p>Skadan ska vara allvarligare \u00e4n den sjukdom du har, enligt <a href=\"https:\/\/lff.se\/om-du-skadas-av-ett-lakemedel\/fragor-och-svar\/\" rel=\"nofollow noopener\" target=\"_blank\">Svenska l\u00e4kemedelsf\u00f6rs\u00e4kringen<\/a>. D\u00e4rf\u00f6r kan en patient med en livshotande sjukdom f\u00e5 avslag, medan en friskare f\u00e5r ers\u00e4ttning f\u00f6r mildare biverkningar.\u00a0<\/p>\n<p>F\u00f6retag som g\u00f6r kliniska pr\u00f6vningar i Sverige m\u00e5ste ha en f\u00f6rs\u00e4kring som omfattar deltagarna, enligt <a href=\"https:\/\/www.lif.se\/fokusomraden\/effektiva-lakemedel-och-en-modern-sjukvard\/patientsamverkan\/att-delta-i-en-klinisk-lakemedelsprovning\/\" rel=\"nofollow noopener\" target=\"_blank\">LIF<\/a>.<\/p>\n<p>\u201dDet \u00e4r en avv\u00e4gning mellan grundsjukdomen och biverkningen\u201d, s\u00e4ger <strong>Anders Hultman<\/strong>, vd f\u00f6r Svenska l\u00e4kemedelsf\u00f6rs\u00e4kringen. Han s\u00e4ger att f\u00f6rs\u00e4kringen inte undantar n\u00e5gon och att varje fall bed\u00f6ms f\u00f6r sig.<\/p>\n<p>\u201dAlla jag har pratat med tycker att det h\u00e4r l\u00e5ter helt absurt\u201d, s\u00e4ger Christer Nilsson. Peter Andersen, professor i neurologi i Ume\u00e5, undrar hur man ska f\u00e5 ALS-patienter att delta i pr\u00f6vningar om de inte f\u00e5r ers\u00e4ttning f\u00f6r biverkningar. Beslutet \u00f6verklagades till L\u00e4kemedelsskaden\u00e4mnden.<\/p>\n<p><strong>MISSA INTE: <\/strong><a href=\"https:\/\/news55.se\/resor\/angtag-vikingar-och-hastar-den-bortglomda-on-som-har-allt\/\" rel=\"nofollow noopener\" target=\"_blank\">\u00c5ngt\u00e5g, vikingar och h\u00e4star \u2013 den bortgl\u00f6mda \u00f6n som har allt<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"Jesper Bj\u00f6rkman, tidigare back i Helsingborgs IF, har ALS. Han deltog i en l\u00e4kemedelsstudie i Sk\u00e5ne som skulle&hellip;\n","protected":false},"author":2,"featured_media":448932,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_share_on_mastodon":"0"},"categories":[69],"tags":[12103,6031,113,112,34,4595,31,33,32,30,5235],"class_list":["post-448931","post","type-post","status-publish","format-standard","has-post-thumbnail","category-halsa","tag-als","tag-forsakring","tag-halsa","tag-health","tag-se","tag-studie","tag-svenska","tag-sverige","tag-sweden","tag-swedish","tag-tips"],"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@se\/117581088466011300","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/posts\/448931","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/comments?post=448931"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/posts\/448931\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/media\/448932"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/media?parent=448931"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/categories?post=448931"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/tags?post=448931"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}